Navigation Links
Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
Date:3/15/2011

MOUNTAIN VIEW, Calif., March 15, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) reported today financial results for the fiscal quarter and year ended December 31, 2010, and provided a general corporate update.  Alexza recorded net income of $25.4 million in the fourth quarter of 2010, while posting a net loss of $1.5 million for the year ended December 31, 2010, as reported in accordance with accounting principles generally accepted in the United States (GAAP), compared to a net loss of $19.8 million and $56.1 million in the quarter and year ended December 31, 2009, respectively.  At December 31, 2010, Alexza had consolidated cash, cash equivalents and marketable securities of $41.4 million.

"All of Alexza has worked very hard over the past months to address the issues raised in the AZ-004 Complete Response Letter," said Thomas B. King, President and CEO of Alexza.  "Based on our End-of-Review meeting with the FDA, ongoing internal work and work with external consultants and advisors, we believe all of the issues raised in the CRL are resolvable.  We remain on track with our plan to resubmit the AZ-004 NDA in July 2011."

Alexza Corporate Update

The following key events occurred since the beginning of the fourth quarter of 2010:

  • Alexza received a Complete Response Letter (CRL) from the U. S. Food and Drug Administration (FDA) to Alexza's New Drug Application (NDA) for AZ-004 Staccato loxapine on October 8, 2010.
  • Alexza reacquired the U.S. and Canadian rights for AZ-004 from Biovail Laboratories International SRL (BLS), now a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc.  All AZ-004 rights reverted to Alexza, effective January 16, 2011.
  • Alexza completed an End-of-Review meeting with the FDA for the AZ-004 NDA in December 2010, and received the FDA minutes from the
    '/>"/>

  • SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
    2. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
    3. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
    4. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
    5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
    6. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
    7. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
    8. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
    9. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
    10. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
    11. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... -- Edwards Lifesciences Corporation (NYSE: EW ), the global ... today announced that Robert A. Ingram has retired ... an ardent champion for innovation in the lifesciences industry, and ... Edwards, board as we pursue our focused innovation strategy," said ... has provided a valuable perspective to our board, drawing on ...
    (Date:7/30/2015)... 30, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... Development Agreements with Dexcom, Inc. to allow the ... the Dexcom G5 and G6 continuous glucose monitoring ... pump platform with Dexcom,s future CGM systems is ...
    (Date:7/30/2015)... Calif., July 30, 2015  Amgen (NASDAQ: ... second quarter of 2015. Key results include: ... second quarter of 2014 to $5,370 million, with ... Enbrel ® (etanercept), Prolia ® (denosumab), ... and XGEVA ® (denosumab). Unfavorable changes in ...
    Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
    ... Tenn., Sept. 3 Nashville-based medical software developer ... been named one of the top 5,000 fastest ... Inc. magazine. This marks the third year ... (Logo:   http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) (Logo: ...
    ... Updates Financial Guidance for 2010 -- HARBIN, China, Sept. 3 /PRNewswire-Asia-FirstCall/ -- ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
    Cached Medicine Technology:INC. 5000 Names ClinixMIS for Third Time 2China Sky One Medical Updates Financial Guidance for 2010 2China Sky One Medical Updates Financial Guidance for 2010 3China Sky One Medical Updates Financial Guidance for 2010 4China Sky One Medical Updates Financial Guidance for 2010 5China Sky One Medical Updates Financial Guidance for 2010 6China Sky One Medical Updates Financial Guidance for 2010 7China Sky One Medical Updates Financial Guidance for 2010 8
    (Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, ... to download on the Apple AppStore. , The app is designed to track ... acting as a tool to view personal health and use this information for positive ...
    (Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the STASH awards ... awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in ... products that have stood the test of time. These include lighting products, organic ...
    (Date:7/31/2015)... ... ... Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, February ... In the two weeks that separate the conference championships and the Super Bowl, there is ... will mark the 50th time it has been held and the festivities will take place ...
    (Date:7/31/2015)... ... July 31, 2015 , ... ... store run by GoodThreads. The store can be accessed by visiting http://www.curemeso.org/store ... of which are customizable. The best part: whenever a product is purchased, the ...
    (Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
    Breaking Medicine News(10 mins):Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3
    ... officials of San Francisco stated that there has been nearly ... the past five years, but also added that their job ... Health had expected new HIV infections to rise 33 percent ... epidemiologist Willi McFarland told The Los Angeles Times, reports foodconsumer.org. ...
    ... Journal of Epidemiology have published that gensing has the anti-cancer ... among women. ,According to foodconsumer.org the study found ... more likely to survive breast cancer. // Those who took ... active social life compared with those who did not take ...
    ... HONG KONG: Hong Kong is taking all precautionary measures against ... on the economic health. After bouncing back with an envious ... needed so authorities are leaving no stone unturned to ... ,A new central poultry slaughtering plant is on the ...
    ... meal is finding itself in myriad plates and palates. People ... chosen, safe substitute for protein, after the bird-flu crisis and ... ,Soy exports have never been so good. In March alone, ... compared to 225,000 tones during the same time ...
    ... twin that got a lifesaving heart transplant left the hospital ... than a month back, two families were in grief, one ... gravely ill baby. //Then in an act of kindness and ... new lease of life. ,The parents of twins Nick ...
    ... researcher, nearly half of the British population are affected by ... risk of osteoporosis or some other forms of cancer.// ... the European Congress of Endocrinology in Glasgow, Scotland, he had ... about half the population -- 225 million people across Europe ...
    Cached Medicine News:Health News:New Lease Of Life For Baby With A Heart Transplant 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: